datamatters24/research-document-archive huggingface dataset:
I 
116TH CONGRESS 
1ST SESSION 
H. R. 974 
To amend the Federal Reserve Act to require the Vice Chairman for Super-
vision of the Board of Governors of the Federal Reserve System to 
provide a written report, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
FEBRUARY 5, 2019 
Mr. GOTTHEIMER (for himself and Mr. LUCAS) introduced the following bill; 
which was referred to the Committee on Financial Services 
A BILL 
To amend the Federal Reserve Act to require the Vice Chair-
man for Supervision of the Board of Governors of the 
Federal Reserve System to provide a written report, and 
for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Federal Reserve Su-
pervision Testimony Clarification Act’’. 
VerDate Sep 11 2014 
04:25 Feb 15, 2019
Jkt 089200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H974.IH
H974
kjohnson on DSK79L0C42 with BILLS
SEC. 2. VICE CHAIRMAN FOR SUPERVISION REPORT RE-
QUIREMENT. 
Paragraph (12) of section 10 of the Federal Reserve 
Act (12 U.S.C. 247b) is amended— 
(1) by redesignating such paragraph as para-
graph (11); and 
(2) in such paragraph— 
(A) by striking ‘‘shall appear’’ and insert-
ing ‘‘shall provide written testimony and ap-
pear’’; and 
(B) by adding at the end the following: 
‘‘If, at the time of any appearance described in 
this paragraph, the position of Vice Chairman 
for Supervision is vacant, the Chairman or their 
designee shall appear instead and provide the 
required written testimony.’’. 
Æ 
VerDate Sep 11 2014 
04:25 Feb 15, 2019
Jkt 089200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6301
E:\BILLS\H974.IH
H974
kjohnson on DSK79L0C42 with BILLS
IIB 
116TH CONGRESS 
1ST SESSION 
H. R. 974 
IN THE SENATE OF THE UNITED STATES 
MARCH 12, 2019 
Received; read twice and referred to the Committee on Banking, Housing, and 
Urban Affairs 
AN ACT 
To amend the Federal Reserve Act to require the Vice Chair-
man for Supervision of the Board of Governors of the 
Federal Reserve System to provide a written report, and 
for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
VerDate Sep 11 2014 
00:12 Mar 13, 2019
Jkt 089200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H974.RFS
H974
pamtmann on DSKBFK8HB2PROD with BILLS
I 
116TH CONGRESS 
1ST SESSION 
H. R. 976 
To direct the Administrator of the Federal Aviation Administration to enter 
into appropriate arrangements with the National Academies of Sciences, 
Engineering, and Medicine to provide for a report on the health impacts 
of air traffic noise and pollution, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
FEBRUARY 5, 2019 
Mr. LYNCH (for himself, Mr. KRISHNAMOORTHI, Mr. TED LIEU of California, 
Ms. ESHOO, Mr. RASKIN, Mr. SMITH of Washington, Mr. QUIGLEY, Mr. 
SHERMAN, 
Ms. 
BROWNLEY
of 
California, 
Mr. 
LIPINSKI, 
Mr. 
LOWENTHAL, Ms. SPEIER, Ms. JUDY CHU of California, Mrs. NAPOLI-
TANO, Ms. SCHAKOWSKY, Ms. BASS, Ms. NORTON, Mr. SUOZZI, and Miss 
RICE of New York) introduced the following bill; which was referred to 
the Committee on Transportation and Infrastructure 
A BILL 
To direct the Administrator of the Federal Aviation Adminis-
tration to enter into appropriate arrangements with the 
National Academies of Sciences, Engineering, and Medi-
cine to provide for a report on the health impacts of 
air traffic noise and pollution, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Air Traffic Noise and 
Pollution Expert Consensus Act of 2019’’. 
VerDate Sep 11 2014 
22:19 Feb 15, 2019
Jkt 089200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H976.IH
H976
kjohnson on DSK79L0C42 with BILLS
SEC. 2. HEALTH IMPACTS OF AIR TRAFFIC NOISE AND POL-
LUTION. 
(a) STUDY.—The Administrator of the Federal Avia-
tion Administration shall enter into appropriate arrange-
ments with the Health and Medicine Division of the Na-
tional Academies of Sciences, Engineering, and Medicine 
under which the Division will— 
(1) not later than 30 days after the date of en-
actment of this Act, convene a committee of experts 
in health and environmental science to examine the 
various health impacts of air traffic noise and pollu-
tion; and 
(2) issue a corresponding expert consensus re-
port that sets forth current scientific knowledge re-
lating to the various health impacts of air traffic 
noise and pollution. 
(b) REPORT.—Upon completion of the consensus re-
port, the Division shall transmit the report to— 
(1) the Administrator; 
(2) the Secretary of Health and Human Serv-
ices; 
(3) the Administrator of the Environmental 
Protection Agency; 
(4) the Committee on Transportation and In-
frastructure and the Committee on Oversight and 
Reform of the House of Representatives; and 
VerDate Sep 11 2014 
22:19 Feb 15, 2019
Jkt 089200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H976.IH
H976
kjohnson on DSK79L0C42 with BILLS
(5) the Committee on Commerce, Science, and 
Transportation and the Committee on Homeland Se-
curity and Governmental Affairs of the Senate. 
Æ 
VerDate Sep 11 2014 
22:19 Feb 15, 2019
Jkt 089200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H976.IH
H976
kjohnson on DSK79L0C42 with BILLS
I 
116TH CONGRESS 
1ST SESSION 
H. R. 977 
To require the Corps of Engineers to notify affected communities before 
releasing water contaminated with cyanobacteria from flood risk manage-
ment projects, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
FEBRUARY 5, 2019 
Mr. MAST introduced the following bill; which was referred to the Committee 
on Transportation and Infrastructure 
A BILL 
To require the Corps of Engineers to notify affected commu-
nities 
before 
releasing 
water 
contaminated 
with 
cyanobacteria from flood risk management projects, and 
for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Toxic Health Threat 
Warning Act of 2019’’. 
VerDate Sep 11 2014 
22:19 Feb 15, 2019
Jkt 089200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H977.IH
H977
kjohnson on DSK79L0C42 with BILLS
SEC. 2. RELEASES OF WATER CONTAMINATED WITH CY-
ANOBACTERIA. 
(a) DETERMINATION.—Before releasing water from 
a flood risk management project, the Secretary shall deter-
mine whether the water is contaminated with cyanobacte-
ria, based on tests conducted by the Secretary, another 
Federal agency, or the State in which the flood risk man-
agement project is located. 
(b) NOTIFICATION.—If the Secretary determines 
under subsection (a) that water to be released from a flood 
risk management project is contaminated with cyanobacte-
ria, the Secretary shall notify the public and affected gov-
ernments of the contamination and planned release, and 
any potential effects on human health, before releasing the 
water. 
(c) DEFINITIONS.—In this section: 
(1) AFFECTED GOVERNMENT.—The term ‘‘af-
fected government’’ means a State, local, or Tribal 
government with jurisdiction over an area that will 
be affected by a release of water from a flood risk 
management project. 
(2) SECRETARY.—The term ‘‘Secretary’’ means 
the Secretary of the Army, acting through the Chief 
of Engineers. 
Æ 
VerDate Sep 11 2014 
22:19 Feb 15, 2019
Jkt 089200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6301
E:\BILLS\H977.IH
H977
kjohnson on DSK79L0C42 with BILLS
(6) PATENT.—The term ‘‘patent’’ means a pat-
ent issued by the United States Patent and Trade-
mark Office. 
(7) 
STATUTORY
EXCLUSIVITY.—The 
term 
‘‘statutory exclusivity’’ means those prohibitions on 
the submission or approval of drug applications 
under 
clauses 
(ii) 
through 
(iv) 
of 
section 
505(c)(3)(E) (5- and 3-year exclusivity), clauses (ii) 
through (iv) of section 505(j)(5)(F) (5-year and 3- 
year exclusivity), section 505(j)(5)(B)(iv) (180-day 
exclusivity), section 527 (orphan drug exclusivity), 
section 505A (pediatric exclusivity), or section 505E 
(qualified infectious disease product exclusivity) of 
the Federal Food, Drug, and Cosmetic Act (21 
U.S.C. 355(c)(3)(E), 355(j)(5)(B)(iv), 355(j)(5)(F), 
360cc, 355a, 355f), or prohibitions on the submis-
sion or licensing of biologics license applications 
under section 351(k)(6) (interchangeable biological 
product exclusivity) or section 351(k)(7) (biological 
product reference product exclusivity) of the Public 
Health Service Act (42 U.S.C. 262(k)(6), (7)). 
(8) SUBSEQUENT
FILER.—The term ‘‘subse-
quent filer’’ means— 
(A) in the case of a drug, a party that 
owns or controls an abbreviated new drug appli-
Traffic Safety Administration on October 15, 2012, in the 
final rule entitled ‘‘2017 and Later Model Year Light- 
Duty Vehicle Greenhouse Gas Emissions and Corporate 
Average Fuel Economy Standards’’ (77 Fed. Reg. 62623), 
including such standards for model years 2022 through 
2025 that were found by the Environmental Protection 
Agency to remain appropriate in the ‘‘Final Determination 
on the Appropriateness of the Model Year 2022–2025 
Light-Duty Vehicle Greenhouse Gas Emissions Standards 
under the Midterm Evaluation’’ issued in January 2017. 
(b) RESTRICTION ON REVISING STANDARDS OR CRE-
ATING NEW LOOPHOLES.—The Administrator of the En-
vironmental Protection Agency may not take any action 
that could effectively reduce the stringency of greenhouse 
gas emission standards required to be attained by each 
fleet of light-duty vehicles manufactured for sale in the 
United States for model years up to and including 2025, 
including by revising the trading, transferring, availability, 
or creation of credits. 
Æ 
VerDate Sep 11 2014 
22:19 Feb 15, 2019
Jkt 089200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6301
E:\BILLS\H978.IH
H978
kjohnson on DSK79L0C42 with BILLS
I 
116TH CONGRESS 
1ST SESSION 
H. R. 979 
To amend the Internal Revenue Code of 1986 to require inclusion of the 
taxpayer’s social security number to claim the refundable portion of 
the child tax credit. 
IN THE HOUSE OF REPRESENTATIVES 
FEBRUARY 5, 2019 
Mr. POSEY (for himself, Mr. WEBER of Texas, Mr. DAVID P. ROE of Ten-
nessee, and Mr. YOHO) introduced the following bill; which was referred 
to the Committee on Ways and Means 
A BILL 
To amend the Internal Revenue Code of 1986 to require 
inclusion of the taxpayer’s social security number to 
claim the refundable portion of the child tax credit. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Refundable Child Tax 
Credit Eligibility Verification Reform Act of 2019’’. 
VerDate Sep 11 2014 
19:10 Feb 19, 2019
Jkt 089200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H979.IH
H979
pbinns on DSK79D2C42PROD with BILLS
SEC. 2. SOCIAL SECURITY NUMBER REQUIRED TO CLAIM 
THE REFUNDABLE PORTION OF THE CHILD 
TAX CREDIT. 
(a) IN GENERAL.—Section 24(d) of the Internal Rev-
enue Code of 1986 is amended by adding at the end the 
following new paragraph: 
‘‘(6) IDENTIFICATION REQUIREMENT.— 
‘‘(A) IN
GENERAL.—Paragraph (1) shall 
not apply to any taxpayer for any taxable year 
unless the taxpayer includes the taxpayer’s so-
cial security number on the return of tax for 
such taxable year. 
‘‘(B) JOINT RETURNS.—In the case of a 
joint return, the requirement of subparagraph 
(A) shall be treated as met if the social security 
number of either spouse is included on such re-
turn. 
‘‘(C) SOCIAL
SECURITY
NUMBER.—For 
purposes of this paragraph, the term ‘social se-
curity number’ means a social security number 
issued to an individual by the Social Security 
Administration (other than a social security 
number issued pursuant to subclause (II) (or 
that portion of subclause (III) that relates to 
subclause (II)) of section 205(c)(2)(B)(i) of the 
Social Security Act).’’. 
VerDate Sep 11 2014 
19:10 Feb 19, 2019
Jkt 089200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H979.IH
H979
pbinns on DSK79D2C42PROD with BILLS
(b) OMISSIONS TREATED
AS MATHEMATICAL
OR 
CLERICAL ERROR.—Section 6213(g)(2)(I) of such Code 
is amended to read as follows: 
‘‘(I) an omission of a correct social secu-
rity number required under section 24(d)(6) 
(relating to refundable portion of child tax cred-
it), or a correct TIN required under section 
24(e) (relating to child tax credit), to be in-
cluded on a return,’’. 
(c) EFFECTIVE DATE.—The amendments made by 
this section shall apply to taxable years beginning after 
December 31, 2019. 
Æ 
VerDate Sep 11 2014 
19:10 Feb 19, 2019
Jkt 089200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H979.IH
H979
pbinns on DSK79D2C42PROD with BILLS
IIB 
116TH CONGRESS 
1ST SESSION 
H. R. 97 
IN THE SENATE OF THE UNITED STATES 
JULY 16, 2019 
Received; read twice and referred to the Committee on Foreign Relations 
AN ACT 
To amend the State Department Basic Authorities Act of 
1956 to authorize rewards for thwarting wildlife traf-
ficking linked to transnational organized crime, and for 
other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
VerDate Sep 11 2014 
22:58 Jul 16, 2019
Jkt 089200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H97.RFS
H97
kjohnson on DSK79L0C42 with BILLS
HR 97 RFS
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Rescuing Animals 
With Rewards Act of 2019’’ or the ‘‘RAWR Act’’. 
SEC. 2. FINDINGS; SENSE OF CONGRESS. 
(a) FINDINGS.—Congress finds the following: 
(1) Wildlife trafficking is a major transnational 
crime that is estimated to generate over $10 billion 
a year in illegal profits and which is increasingly 
perpetrated by organized, sophisticated criminal en-
terprises, including known terrorist organizations. 
(2) Wildlife trafficking not only threatens en-
dangered species worldwide, but also jeopardizes 
local security, spreads disease, undermines rule of 
law, fuels corruption, and damages economic devel-
opment. 
(3) Combating wildlife trafficking requires a co-
ordinated and sustained approach at the global, re-
gional, national, and local levels. 
(4) Congress stated in the Eliminate, Neu-
tralize, and Disrupt Wildlife Trafficking Act of 2016 
that it is the policy of the United States to take im-
mediate actions to stop the illegal global trade in 
wildlife and wildlife products and associated transna-
tional organized crime. 
(b) SENSE OF CONGRESS.—It is the sense of Con-
gress that the Department of State’s rewards program is 
VerDate Sep 11 2014 
22:58 Jul 16, 2019
Jkt 089200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H97.RFS
H97
kjohnson on DSK79L0C42 with BILLS
HR 97 RFS
a powerful tool in combating sophisticated international 
crime and that the Department of State and Federal law 
enforcement should work in concert to offer rewards that 
target wildlife traffickers. 
SEC. 3. REWARDS FOR JUSTICE. 
Subparagraph (B) of section 36(k)(5) of the State 
Department Basic Authorities Act of 1956 (22 U.S.C. 
2708(k)(5)) is amended by inserting ‘‘wildlife trafficking 
(as defined by section 2(12) of the Eliminate, Neutralize, 
and Disrupt Wildlife Trafficking Act of 2016 (16 U.S.C. 
7601(12); Public Law 114–231)) and’’ after ‘‘includes’’. 
Passed the House of Representatives July 15, 2019. 
Attest: 
CHERYL L. JOHNSON, 
Clerk. 
VerDate Sep 11 2014 
22:58 Jul 16, 2019
Jkt 089200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H97.RFS
H97
kjohnson on DSK79L0C42 with BILLS
cation submitted pursuant to section 505(j) of 
the Federal Food, Drug, and Cosmetic Act (21 
U.S.C. 355(j)) or a new drug application sub-
mitted pursuant to section 505(b)(2) of the 
Federal 
Food, 
Drug, 
and 
Cosmetic 
Act 
(21U.S.C. 355(b)(2)) and filed under section 
505(b)(1) of such Act (21 U.S.C. 355(b)(1)) or 
has the exclusive rights to distribute the cov-
ered product that is the subject of such applica-
tion; or 
(B) in the case of a biological product, a 
party that owns or controls an application filed 
with the Food and Drug Administration under 
section 351(k) of the Public Health Service Act 
(42 U.S.C. 262(k)) or has the exclusive rights 
to distribute the biological product that is the 
subject of such application. 
(h) EFFECTIVE DATE.—This section applies with re-
spect to agreements described in subsection (a) entered 
into on or after the date of the enactment of this Act. 
SEC. 112. NOTICE AND CERTIFICATION OF AGREEMENTS. 
(a) NOTICE OF ALL AGREEMENTS.—Section 1111(7) 
of the Medicare Prescription Drug, Improvement, and 
Modernization Act of 2003 (21 U.S.C. 355 note) is 
amended by inserting ‘‘or the owner of a patent for which
under section 505–1(f) of the Federal Food, Drug, 
and Cosmetic Act (21 U.S.C. 355–1(f)); 
(8) the term ‘‘Secretary’’ means the Secretary 
of Health and Human Services; 
(9) the term ‘‘single, shared system of elements 
to assure safe use’’ means a single, shared system 
of elements to assure safe use under section 505– 
1(f) of the Federal Food, Drug, and Cosmetic Act 
(21 U.S.C. 355–1(f)); and 
(10) the term ‘‘sufficient quantities’’ means an 
amount of a covered product that the eligible prod-
uct developer determines allows it to— 
(A) conduct testing to support an applica-
tion under— 
(i) subsection (b)(2) or (j) of section 
505 of the Federal Food, Drug, and Cos-
metic Act (21 U.S.C. 355); or 
(ii) section 351(k) of the Public 
Health Service Act (42 U.S.C. 262(k)); 
and 
(B) fulfill any regulatory requirements re-
lating to approval of such an application. 
(b) CIVIL ACTION FOR FAILURE TO PROVIDE SUFFI-
CIENT QUANTITIES OF A COVERED PRODUCT.—
SEC. 2. DEFINITIONS. 
In this Act: 
(1) ELIGIBLE FEDERAL LAND.—The term ‘‘eli-
gible Federal land’’ means— 
(A) any federally owned land or interest in 
land depicted on the Maps as within the Hunter 
Creek and Pistol River Headwaters Withdrawal 
Proposal or the Rough and Ready and Baldface 
Creeks Mineral Withdrawal Proposal; or 
(B) any land or interest in land located 
within such withdrawal proposals that is ac-
quired by the Federal Government after the 
date of enactment of this Act. 
(2) MAPS.—The term ‘‘Maps’’ means— 
(A) the Bureau of Land Management map 
entitled ‘‘Hunter Creek and Pistol River Head-
waters Withdrawal Proposal’’ dated January 
12, 2015; and 
(B) the Bureau of Land Management map 
entitled ‘‘Rough and Ready and Baldface 
Creeks Mineral Withdrawal Proposal’’ dated 
January 12, 2015. 
SEC. 3. WITHDRAWAL OF FEDERAL LAND, CURRY COUNTY 
AND JOSEPHINE COUNTY, OREGON. 
(a) WITHDRAWAL.—Subject to valid existing rights, 
the eligible Federal land is withdrawn from all forms of— 
VerDate Sep 11 2014 
02:02 Feb 15, 2019
Jkt 089200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H992.IH
H992
pamtmann on DSKBFK8HB2PROD with BILLS
or under section 102(a)(1)(F) that is 
foreseeable,’’; and 
(II) in subparagraph (A), by in-
serting after ‘‘to exceed’’ the fol-
lowing: ‘‘(except in the case of leave 
under section 102(a)(1)(F))’’; 
(ii) in subsection (c)(2), by striking 
‘‘section 102(e)(2)’’ and inserting ‘‘para-
graphs (2) and (4) of section 102(e), as 
applicable’’; and 
(iii) in subsection (d), in paragraph 
(2) and (3), by striking ‘‘or (C)’’ each 
place it appears and inserting ‘‘(C), or 
(F)’’. 
(b) FAMILY LEAVE FOR CIVIL SERVICE EMPLOY-
EES.— 
(1) 
ENTITLEMENT
TO
LEAVE.—Section 
6382(a)(1) of title 5, United States Code, is amend-
ed by adding at the end the following: 
‘‘(F) Because of the death of a son or daugh-
ter.’’. 
(2) REQUIREMENTS RELATING TO LEAVE.— 
(A) SCHEDULE.—Section 6382(b)(1) of 
such title is amended by inserting after the 
third sentence the following new sentence: 
VerDate Sep 11 2014 
22:20 Feb 15, 2019
Jkt 089200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H983.IH
H983
kjohnson on DSK79L0C42 with BILLS
‘‘Leave under subsection (a)(1)(F) shall not be 
taken by an employee intermittently or on a re-
duced leave schedule unless the employee and 
the employing agency of the employee agree 
otherwise.’’. 
(B) SUBSTITUTION OF PAID LEAVE.—Sec-
tion 6382(d) of such title is amended, in the 
first sentence, by striking ‘‘or (E)’’ and insert-
ing ‘‘(E), or (F)’’. 
(C) NOTICE.—Section 6382(e) of such title 
is amended by adding at the end the following 
new paragraph: 
‘‘(4) In any case in which the necessity for leave 
under subsection (a)(1)(F) is foreseeable, the employee 
shall provide such notice to the employing agency as is 
reasonable and practicable.’’. 
(D) 
CERTIFICATION
REQUIREMENTS.— 
Section 6383 of such title is amended by adding 
at the end the following: 
‘‘(g) An employing agency may require that a request 
for leave under section 6382(a)(1)(F) be supported by a 
certification issued at such time and in such manner as 
the Office of Personnel Management may by regulation 
prescribe. If the Office issues a regulation requiring such 
VerDate Sep 11 2014 
22:20 Feb 15, 2019
Jkt 089200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H983.IH
H983
kjohnson on DSK79L0C42 with BILLS
certification, the employee shall provide, in a timely man-
ner, a copy of such certification to the employer.’’. 
Æ 
VerDate Sep 11 2014 
22:20 Feb 15, 2019
Jkt 089200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6301
E:\BILLS\H983.IH
H983
kjohnson on DSK79L0C42 with BILLS
I 
116TH CONGRESS 
1ST SESSION 
H. R. 985 
To amend the Federal Food, Drug, and Cosmetic Act to ensure that eligible 
product developers have competitive access to approved drugs and li-
censed biological products, so as to enable eligible product developers 
to develop and test new products, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
FEBRUARY 5, 2019 
Mr. WELCH (for himself, Mr. MCKINLEY, and Mr. CICILLINE) introduced the 
following bill; which was referred to the Committee on Energy and Commerce 
A BILL 
To amend the Federal Food, Drug, and Cosmetic Act to 
ensure that eligible product developers have competitive 
access to approved drugs and licensed biological prod-
ucts, so as to enable eligible product developers to de-
velop and test new products, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Fair Access for Safe 
and Timely Generics Act of 2019’’ or the ‘‘FAST Generics 
Act of 2019’’. 
VerDate Sep 11 2014 
22:04 Feb 16, 2019
Jkt 089200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H985.IH
H985
pbinns on DSK79D2C42PROD with BILLS
deter the license holder from failing to pro-
vide eligible product developers with suffi-
cient quantities of a covered product on 
commercially 
reasonable, 
market-based 
terms, if the court finds, by a preponder-
ance of the evidence— 
(I) that the license holder delayed 
providing sufficient quantities of the 
covered product to the eligible product 
developer without a legitimate busi-
ness justification; or 
(II) that the license holder failed 
to comply with an order issued under 
clause (i). 
(B) MAXIMUM
MONETARY
AMOUNT.—A 
monetary amount awarded under subparagraph 
(A)(iii) shall not be greater than the revenue 
that the license holder earned on the covered 
product during the period— 
(i) beginning on— 
(I) for a covered product that is 
not subject to a REMS with ETASU, 
the date that is 31 days after the date 
on which the license holder received 
the request; or
Calendar No. 90 
116TH CONGRESS 
1ST SESSION 
H. R. 986 
AN ACT 
To provide that certain guidance related to waivers 
for State innovation under the Patient Protection 
and Affordable Care Act shall have no force or 
effect. 
MAY 15, 2019 
Read the second time and placed on the calendar 
VerDate Sep 11 2014 
02:47 May 16, 2019
Jkt 089200
PO 00000
Frm 00006
Fmt 6651
Sfmt 6651
E:\BILLS\H986.PCS
H986
pbinns on DSK79D2C42PROD with BILLS